Literature DB >> 25048542

Avian influenza virus transmission to mammals.

S Herfst1, M Imai, Y Kawaoka, R A M Fouchier.   

Abstract

Influenza A viruses cause yearly epidemics and occasional pandemics. In addition, zoonotic influenza A viruses sporadically infect humans and may cause severe respiratory disease and fatalities. Fortunately, most of these viruses do not have the ability to be efficiently spread among humans via aerosols or respiratory droplets (airborne transmission) and to subsequently cause a pandemic. However, adaptation of these zoonotic viruses to humans by mutation or reassortment with human influenza A viruses may result in airborne transmissible viruses with pandemic potential. Although our knowledge of factors that affect mammalian adaptation and transmissibility of influenza viruses is still limited, we are beginning to understand some of the biological traits that drive airborne transmission of influenza viruses among mammals. Increased understanding of the determinants and mechanisms of airborne transmission may aid in assessing the risks posed by avian influenza viruses to human health, and preparedness for such risks. This chapter summarizes recent discoveries on the genetic and phenotypic traits required for avian influenza viruses to become airborne transmissible between mammals.

Entities:  

Mesh:

Year:  2014        PMID: 25048542     DOI: 10.1007/82_2014_387

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  31 in total

Review 1.  Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus.

Authors:  Clayton A Wiley; Nitin Bhardwaj; Ted M Ross; Stephanie J Bissel
Journal:  Brain Pathol       Date:  2015-09       Impact factor: 6.508

2.  Evaluation of multivalent H2 influenza pandemic vaccines in mice.

Authors:  Brian J Lenny; Stephanie Sonnberg; Angela F Danner; Kimberly Friedman; Richard J Webby; Robert G Webster; Jeremy C Jones
Journal:  Vaccine       Date:  2017-02-08       Impact factor: 3.641

Review 3.  CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential.

Authors:  Andrea J Sant; Anthony T DiPiazza; Jennifer L Nayak; Ajitanuj Rattan; Katherine A Richards
Journal:  Immunol Rev       Date:  2018-07       Impact factor: 12.988

4.  Influenza hemagglutinin (HA) stem region mutations that stabilize or destabilize the structure of multiple HA subtypes.

Authors:  Lauren Byrd-Leotis; Summer E Galloway; Evangeline Agbogu; David A Steinhauer
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

Review 5.  Population Diversity and Collective Interactions during Influenza Virus Infection.

Authors:  Christopher B Brooke
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

6.  Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity.

Authors:  Stuart D Dowall; David A Matthews; Isabel Garcia-Dorival; Irene Taylor; John Kenny; Christiane Hertz-Fowler; Neil Hall; Kara Corbin-Lickfett; Cyril Empig; Kyle Schlunegger; John N Barr; Miles W Carroll; Roger Hewson; Julian A Hiscox
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

7.  H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial.

Authors:  Larisa Rudenko; Irina Isakova-Sivak; Anatoly Naykhin; Irina Kiseleva; Marina Stukova; Mariana Erofeeva; Daniil Korenkov; Victoria Matyushenko; Erin Sparrow; Marie-Paule Kieny
Journal:  Lancet Infect Dis       Date:  2015-12-08       Impact factor: 25.071

8.  S-Acylation of Proteins of Coronavirus and Influenza Virus: Conservation of Acylation Sites in Animal Viruses and DHHC Acyltransferases in Their Animal Reservoirs.

Authors:  Dina A Abdulrahman; Xiaorong Meng; Michael Veit
Journal:  Pathogens       Date:  2021-05-29

Review 9.  Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head.

Authors:  Lidewij C M Wiersma; Guus F Rimmelzwaan; Rory D de Vries
Journal:  Vaccines (Basel)       Date:  2015-03-26

10.  Characterization of a Pathogenic Full-Length cDNA Clone and Transmission Model for Porcine Epidemic Diarrhea Virus Strain PC22A.

Authors:  Anne Beall; Boyd Yount; Chun-Ming Lin; Yixuan Hou; Qiuhong Wang; Linda Saif; Ralph Baric
Journal:  mBio       Date:  2016-01-05       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.